NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -864.41 Million JPY | 30.62% |
| 2022 | -1.24 Billion JPY | 39.55% |
| 2021 | -2.06 Billion JPY | -58.19% |
| 2020 | -1.3 Billion JPY | -17.82% |
| 2019 | -1.1 Billion JPY | 38.65% |
| 2018 | -1.8 Billion JPY | 66.32% |
| 2017 | -5.35 Billion JPY | -97.31% |
| 2016 | -2.71 Billion JPY | -30.23% |
| 2015 | -2.08 Billion JPY | -87.93% |
| 2014 | -1.1 Billion JPY | 1.32% |
| 2013 | -1.12 Billion JPY | -113.2% |
| 2012 | -526.76 Million JPY | -57.93% |
| 2011 | -333.54 Million JPY | 35.85% |
| 2010 | -519.92 Million JPY | -5.53% |
| 2009 | -492.69 Million JPY | 7.36% |
| 2008 | -531.81 Million JPY | -17.52% |
| 2007 | -452.53 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -189 Million JPY | -6.76% |
| 2023 Q3 | -168.75 Million JPY | 21.36% |
| 2023 Q4 | -177.03 Million JPY | -4.91% |
| 2023 Q1 | -304.03 Million JPY | -98.36% |
| 2023 Q2 | -214.59 Million JPY | 29.42% |
| 2023 FY | -864.41 Million JPY | 30.62% |
| 2022 Q1 | -397.7 Million JPY | 28.57% |
| 2022 Q4 | -153.27 Million JPY | 61.26% |
| 2022 FY | -1.24 Billion JPY | 39.55% |
| 2022 Q2 | -299.38 Million JPY | 24.72% |
| 2022 Q3 | -395.64 Million JPY | -32.15% |
| 2021 Q3 | -472.13 Million JPY | 11.58% |
| 2021 Q4 | -556.78 Million JPY | -17.93% |
| 2021 Q2 | -533.99 Million JPY | -7.19% |
| 2021 Q1 | -498.17 Million JPY | -12.56% |
| 2021 FY | -2.06 Billion JPY | -58.19% |
| 2020 FY | -1.3 Billion JPY | -17.82% |
| 2020 Q2 | -296.47 Million JPY | -38.57% |
| 2020 Q3 | -349.86 Million JPY | -18.01% |
| 2020 Q4 | -442.58 Million JPY | -26.5% |
| 2020 Q1 | -213.95 Million JPY | -23.38% |
| 2019 Q1 | -499.49 Million JPY | -51.88% |
| 2019 Q4 | -173.41 Million JPY | 30.21% |
| 2019 FY | -1.1 Billion JPY | 38.65% |
| 2019 Q2 | -184.41 Million JPY | 63.08% |
| 2019 Q3 | -248.47 Million JPY | -34.74% |
| 2018 FY | -1.8 Billion JPY | 66.32% |
| 2018 Q4 | -328.87 Million JPY | 39.65% |
| 2018 Q3 | -544.95 Million JPY | -89.37% |
| 2018 Q1 | -640.71 Million JPY | 2.1% |
| 2018 Q2 | -287.76 Million JPY | 55.09% |
| 2017 Q3 | -2.61 Billion JPY | -219.72% |
| 2017 Q1 | -1.26 Billion JPY | -61.72% |
| 2017 FY | -5.35 Billion JPY | -97.31% |
| 2017 Q4 | -654.47 Million JPY | 74.99% |
| 2017 Q2 | -818.5 Million JPY | 35.12% |
| 2016 Q2 | -661.41 Million JPY | -7.61% |
| 2016 Q1 | -614.63 Million JPY | 5.71% |
| 2016 Q4 | -780.07 Million JPY | -18.9% |
| 2016 Q3 | -656.09 Million JPY | 0.8% |
| 2016 FY | -2.71 Billion JPY | -30.23% |
| 2015 Q3 | -509.09 Million JPY | -6.01% |
| 2015 Q1 | -441.5 Million JPY | -136.65% |
| 2015 Q4 | -651.84 Million JPY | -28.04% |
| 2015 Q2 | -480.23 Million JPY | -8.77% |
| 2015 FY | -2.08 Billion JPY | -87.93% |
| 2014 Q1 | -381.74 Million JPY | -12.77% |
| 2014 FY | -1.1 Billion JPY | 1.32% |
| 2014 Q4 | -186.55 Million JPY | 54.94% |
| 2014 Q3 | -414.06 Million JPY | -229.0% |
| 2014 Q2 | -125.85 Million JPY | 67.03% |
| 2013 FY | -1.12 Billion JPY | -113.2% |
| 2013 Q2 | -223.84 Million JPY | 19.29% |
| 2013 Q3 | -283.33 Million JPY | -26.58% |
| 2013 Q4 | -338.51 Million JPY | -19.47% |
| 2013 Q1 | -277.35 Million JPY | -67.28% |
| 2012 FY | -526.76 Million JPY | -57.93% |
| 2012 Q3 | -94.37 Million JPY | -7.43% |
| 2012 Q2 | -87.84 Million JPY | 50.85% |
| 2012 Q4 | -165.8 Million JPY | -75.69% |
| 2012 Q1 | -178.74 Million JPY | -263.5% |
| 2011 Q4 | -49.17 Million JPY | 72.03% |
| 2011 Q1 | -153.56 Million JPY | -19.92% |
| 2011 FY | -333.54 Million JPY | 35.85% |
| 2011 Q3 | -175.77 Million JPY | -490.95% |
| 2011 Q2 | 44.96 Million JPY | 129.28% |
| 2010 Q1 | -145.4 Million JPY | -17.75% |
| 2010 Q4 | -128.05 Million JPY | -23.94% |
| 2010 Q3 | -103.32 Million JPY | 27.82% |
| 2010 Q2 | -143.14 Million JPY | 1.56% |
| 2010 FY | -519.92 Million JPY | -5.53% |
| 2009 Q2 | -124.37 Million JPY | 21.32% |
| 2009 Q3 | -86.76 Million JPY | 30.24% |
| 2009 FY | -492.69 Million JPY | 7.36% |
| 2009 Q4 | -123.48 Million JPY | -42.32% |
| 2009 Q1 | -158.07 Million JPY | -74.65% |
| 2008 Q3 | -145.25 Million JPY | 0.0% |
| 2008 Q4 | -90.5 Million JPY | 37.69% |
| 2008 FY | -531.81 Million JPY | -17.52% |
| 2007 FY | -452.53 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 244.836% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -73.973% |
| GNI Group Ltd. | 13.1 Billion JPY | 106.594% |
| Linical Co., Ltd. | 725.72 Million JPY | 219.111% |
| Trans Genic Inc. | 89.43 Million JPY | 1066.518% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 39.38% |
| Soiken Holdings Inc. | -610 Million JPY | -41.706% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -11.863% |
| AnGes, Inc. | -11.96 Billion JPY | 92.777% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 22.875% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 90.926% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 928.786% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 22.611% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 31.504% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -8.247% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -156.225% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 28.274% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 35.279% |
| PeptiDream Inc. | 6.77 Billion JPY | 112.763% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 55.211% |
| Ribomic Inc. | -1.11 Billion JPY | 22.557% |
| SanBio Company Limited | -4.53 Billion JPY | 80.956% |
| Healios K.K. | -3.37 Billion JPY | 74.418% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 25.164% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 37.969% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 38.388% |
| StemRIM | -2.07 Billion JPY | 58.362% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 170.767% |
| FunPep Company Limited | -994 Million JPY | 13.037% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 2.739% |
| Stella Pharma Corporation | -760.3 Million JPY | -13.694% |
| TMS Co., Ltd. | -943.25 Million JPY | 8.358% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -11.481% |
| Cuorips Inc. | -588.48 Million JPY | -46.888% |
| K Pharma,Inc. | 366.05 Million JPY | 336.142% |
| Takara Bio Inc. | 3 Billion JPY | 128.785% |
| ReproCELL Incorporated | -409.29 Million JPY | -111.197% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 7913.568% |
| StemCell Institute Inc. | 413.75 Million JPY | 308.918% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 698.182% |
| CellSeed Inc. | -697.77 Million JPY | -23.881% |